drugset / Trial / NCT01001195
Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the safety, efficacy and dose-response of AGN-210669. This study will also compare AGN-210669 with bimatoprost ophthalmic solution (LUMIGAN®).
Timeline
- Start
- 2009-11
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bimatoprost | Other / unclassified | 0.03 % | Other |
| Subject | SIMENEPAG ISOPROPYL | Small molecule | 0.05 % | Other |
| Subject | SIMENEPAG ISOPROPYL | Small molecule | 0.075 % | Other |
| Subject | SIMENEPAG ISOPROPYL | Small molecule | 0.1 % | Other |